Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The porphyrin pathway, also known as the heme biosynthetic pathway, is a highly conserved metabolic route responsible for the synthesis and breakdown of porphyrins—macrocyclic organic compounds composed of four pyrrole subunits linked by methine bridges. This pathway is essential in both animals and plants, leading to the production of critical molecules such as heme (in animals) and chlorophyll (in plants). Defects in this pathway cause *porphyrias*, a group of rare genetic disorders characterized by accumulation of toxic precursors or photoactive porphyrins. These manifest with neurovisceral symptoms or cutaneous photosensitivity depending on which intermediate accumulates.
Inhibition of specific enzymes within the pathway to reduce accumulation of toxic intermediates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porphyrin Pathway.